Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Takeda reports positive Phase IIIb results for vedolizumab

Vedolizumab IV is approved for adults with moderately to severely active ulcerative colitis and Crohn’s disease. Credit: RicHard-59.



  • Takeda reports positive Phase IIIb results for vedolizumab

Go Top